Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 3 2Phase 1 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Uterine Cervical Neoplasms 1Papillomavirus Infections 1Cervical Intraepithelial Neoplasia Grade 2/3 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 4Imiquimod 3VGX-3100 2Conization 2Colposcopy 2Blood Specimen Collection 2lime 1hecolin 1Vaginal Smears 1Vaccines, Synthetic 1Spectrometry, Fluorescence 1Polymerase Chain Reaction 1Papillomavirus Vaccines 1Olive Oil 1Mass Screening 1Isotretinoin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hepatitis A Vaccines 1Fluorouracil 1Fenretinide 1Electroporation 1Cryosurgery 1AKAP13 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Uterine Cervical Dysplasia × Colposcopy × Clear all
NCT01131312 2018-11-20

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
5,060 enrolled 10 charts
Gynecologic

Uterine Cervical Dysplasia

NCT00529464 2016-05-09

Spectroscopy Versus Standard Care in Cervical Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Terminated
2 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡